SGMO
Sangamo Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.38
-0.02 ▼ -4.52%
🌙 3월 13일 7:43 PM ET (한국 3/14 08:43)
$0.38
+0.00 +0.48%
| Index | - | P/E | - | EPS (ttm) | -0.44 | Insider Own | 2.15% | Shs Outstand | 0.37B | Perf Week | 0.19% |
| Market Cap | 0.14B | Forward P/E | - | EPS next Y | 21.03% | Insider Trans | - | Shs Float | 0.36B | Perf Month | -3.35% |
| Enterprise Value | 0.14B | PEG | - | EPS next Q | 0.01 | Inst Own | 16.87% | Short Float | 9.09% | Perf Quarter | -21.63% |
| Income | -0.11B | P/S | 4.28 | EPS this Y | 36.89% | Inst Trans | -0.08% | Short Ratio | 5.86 | Perf Half Y | -28.88% |
| Sales | 0.03B | P/B | 19.5 | EPS next 5Y | 73.79% | ROA | -108.96% | Short Interest | 33.07M | Perf YTD | -9.95% |
| Book/sh | 0.02 | P/C | 4.6 | EPS past 3/5Y | 26.7% 10.57% | ROE | -480.02% | 52W High | -63.63% ($1.04) | Perf Year | -59.06% |
| Cash/sh | 0.08 | P/FCF | - | Sales past 3/5Y | -19.48% -10.81% | ROIC | -343.92% | 52W Low | 9.62% ($0.34) | Perf 3Y | -83.19% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 40.47% | Gross Margin | 76.11% | Volatility(W/M) | 7.5% 8.88% | Perf 5Y | -96.72% |
| Dividend TTM | - | EV/Sales | 4.12 | Sales Y/Y TTM | -37.13% | Oper. Margin | -335.55% | ATR (14) | 0.04 | Perf 10Y | -93.7% |
| Dividend Ex-Date | - | Quick Ratio | 0.88 | EPS Q/Q | -362.1% | Profit Margin | -331.28% | RSI (14) | 44 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.88 | Sales Q/Q | -98.82% | SMA20 | -6.27% ($0.41) | Beta | 1.33 | Target Price | $3.81 |
| Payout | - | Debt/Eq | 4.07 | Earnings | 11000000 | SMA50 | -8.47% ($0.42) | Rel Volume | 0.72 | Prev Close | $0.4 |
| Employees | 183 | LT Debt/Eq | 4.07 | EPS/Sales Surpr. | -21900% -98.31% | SMA200 | -24.49% ($0.5) | Avg Volume(3M) | 5.65M | Price | $0.38 |
| IPO | 2000/4/6 | Option/Short | Yes/Yes | Trades | 4753 | Volume | 4,073,037 | Change | -4.52% |
뉴스 로딩 중...